[1] Li B, He X, Dong Z, et al. Ionomycin ameliorates hypophosphatasia via rescuing alkaline phosphatase deficiency-mediated L-type Ca channel internalization in mesenchymal stem cells [J]. Bone Res, 2020, 8(1):19. [2] Bianchi M, Bishop N, Guañabens N, et al. Hypophosphatasia in adolescents and adults: overview of diagnosis and treatment [J]. Osteoporos Int, 2020, 31(8):1445-1460. [3] Cheng P, Li D, Gao Y, et al. Prevascularization promotes endogenous cell-mediated angiogenesis by upregulating the expression of fibrinogen and connective tissue growth factor in tissue-engineered bone grafts [J]. Stem Cell Res Ther, 2018, 9(1):176. [4] 卢永超,王伟,吕翱,等.炎症微环境下骨髓间充质干细胞骨向分化中Periostin基因表达研究[J].口腔医学研究,2020,36(12):1148-1152. [5] Gonzalez-King H, Garcia NA, Ontoria-Oviedo I, et al. Hypoxia inducible factor-1alpha potentiates jagged 1-mediated angiogenesis by mesenchymal stem cell-derived exosomes [J]. Stem Cells, 2017, 35(7):1747-1759. [6] Liu L, Liu Y, Feng C, et al. Lithium-containing biomaterials stimulate bone marrow stromal cell-derived exosomal miR-130a secretion to promote angiogenesis [J]. Biomaterials, 2019, 192:523-536. [7] Lu Y, Zhou Y, Zhang R, et al. Bone mesenchymal stem cell-derived extracellular vesicles promote recovery following spinal cord injury via improvement of the integrity of the blood-spinal Cord barrier [J]. Front Neurosci, 2019, 13:209. [8] 陈燕,姜胜军,彭友俭.骨髓间充质干细胞来源的外泌体对成骨细胞增殖和分化的影响[J].口腔医学研究,2019,35(4):401-404. [9] Liu W, Zhang L, Xuan K, et al. Alpl prevents bone ageing sensitivity by specifically regulating senescence and differentiation in mesenchymal stem cells [J]. Bone Res, 2018, 6:27. [10] Liu W, Zhang L, Xuan K, et al. Alkaline phosphatase controls lineage switching of mesenchymal stem cells by regulating the LRP6/GSK3beta complex in hypophosphatasia [J]. Theranostics, 2018, 8(20):5575-5592. [11] Alonso N, Larraz-Prieto B, Berg K, et al. Loss-of-function mutations in the ALPL gene presenting with adult onset osteoporosis and low serum concentrations of total alkaline phosphatase [J]. Bone Miner Res, 2020, 35(4):657-661. [12] Kishnani PS, Rockman-Greenberg C, Rauch F, et al. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia [J]. Bone, 2019, 121:149-162. [13] 叶庆元,邱新毓,田荣,等.供体MSCs来源的外泌体转运miR-26a恢复宿主MSCs功能并缓解骨质疏松[J].实用口腔医学杂志,2017,33(5):575-579. [14] Phinney DG, Pittenger MF. Concise review: MSC-derived exosomes for cell-free therapy [J]. Stem Cells, 2017, 35(4):851-858. [15] Farooqi AA, Desai NN, Qureshi MZ, et al. Exosome biogenesis, bioactivities and functions as new delivery systems of natural compounds [J]. Biotechnol Adv, 2018, 36(1):328-334. [16] Barile L, Vassalli G. Exosomes: therapy delivery tools and biomarkers of diseases [J]. Pharmacol Ther, 2017, 174:63-78. |